Neuren Pharmaceuticals Limited NEU.AX · Stock Open Neuren Pharmaceuticals Limited in new tab
Neuren Pharmaceuticals Limited Analysis (NEU.AX)
Is Neuren Pharmaceuticals Limited a good investment? Neuren Pharmaceuticals Limited (NEU.AX) is currently trading at 20.33 AUD. Market analysts have a consensus price target of 26.03 AUD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 134.27. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Neuren Pharmaceuticals Limited is expected to release its next earnings report on Feb. 24, 2027. The market consensus estimate for Forward EPS is 0.60.
Investor FAQ
Does Neuren Pharmaceuticals Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Neuren Pharmaceuticals Limited?
Neuren Pharmaceuticals Limited is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Feb. 24, 2027. The company currently has a trailing EPS of 0.15.
Company Profile
Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid; and in Phase 2 clinical trial for the treatment of Angelman and Pitt Hopkins. In addition, it develops NNZ-2591, which is in preclinical trial stage for the treatment of Prader-Willi syndrome, Hypoxic Ischemic Encephalopathy, and SYNGAP1. The company was incorporated in 2001 and is based in Hawthorn East, Australia.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.15 AUD
|
| Oct. 7, 2026 | 0.1500 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Neuren Pharmaceuticals Limited | Oct 07, 2026 | Paid | 0.15 AUD |
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 24, 2007 | 1.02 |
| June 21, 2011 | 1.1 |
| Nov. 21, 2017 | 1:20 |
Community Discussion